9/30/22

Therapeutic options of post-COVID-19 related olfactory dysfunction: a systematic review and meta-analysis 

Asvapoositkul V, Samuthpongtorn J, Aeumjaturapat S, et al. | Rhinology

Aim: To consolidate existing evidence for current therapies in patients with persistent olfactory dysfunction related to COVID-19 infection and evaluate the possible role of corticosteroid add-on therapy in olfactory training.

9/26/22

Interventions for Improving Long COVID-19 Symptomatology: A Systematic Review   

Veronese N, Bonica R, Cotugno S, et al. | Viruses

Aim: To understand which therapies have proved effective against the symptoms of long COVID-19.

9/20/22

Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis 

Keikha M, Karbalaei M | Microb Pathog

Aim: To investigate the effect of polymorphisms such as rs4646994 and rs2285666 on susceptibility to coronavirus disease-2019 (COVID-19).

9/19/22

Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review   

Kulper-Schiek W, Piechotta V, Pilic A, et al. | Front Immunol

Aim: To summarize evidence on the effectiveness of the coronavirus disease 2019 (COVID-19) vaccine (vaccine effectiveness, VE) and duration of protection against Omicron.

9/19/22

Prevalence and clinical presentation of long COVID in children: a systematic review   

Pellegrino R, Chiappini E, Licari A, et al. | Eur J Pediatr

Aim: To summarize the current evidence regarding Long COVID in children, with a focus on prevalence and clinical presentation.

9/6/22

Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review   

Notarte KI, Catahay JA, Velasco JV, et al. | EClinicalMedicine

Aim: To review the evidence on the impact of COVID-19 vaccines on the risk of developing long-COVID or on existing long-COVID in COVID-19 survivors.

9/6/22

Just When We Thought That COVID Was Over: A Systematic Review   

Tariq M, Acharekar MV, Guerrero Saldivia SE, et al. | Cureus

Aim: To focus on the two main long-standing symptoms, fatigue and headaches, resulting in poor work performance and difficulty in performing daily activities of life.

8/30/22

Post-COVID-19 fatigue: A systematic review   

Joli J, Buck P, Zipfel S, et al. | Front Psychiatry

Aim: To describe all symptoms related to post-COVID-19 fatigue, its possible etiology and risk factors as well as treatment approaches employed so far.

8/29/22

Role of Nuclear Factor Erythroid 2 (Nrf2) in the Recovery of Long COVID-19 Using Natural Antioxidants: A Systematic Review   

Muchtaridi M, Amirah SR, Harmonis JA, et al. | Antioxidants

Aim: To review the evidence on the prospect of utilizing natural antioxidants as long-term treatment for COVID-19 via the Nrf2 signaling pathway. 

8/26/22

COVID-19 postacute care major organ damage: a systematic review   

Greer N, Bart B, Billington CJ, et al. | BMJ Open

Aim: To examine major organ damage postdischarge among adults hospitalised for COVID-19 versus non-COVID-19 controls.

8/26/22

Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis   

Choudhury A, Tariq R, Jena A, et al. | Therap Adv Gastroenterol

Aim: To assess the GI manifestation of ‘long COVID’ and the frequency of these manifestations.

8/23/22

Prevalence of Fungal Drug Resistance in COVID-19 Infection: a Global Meta-analysis   

Habibzadeh A, Lankarani KB, Farjam M, et al. | Curr Fungal Infect Rep

Aim: To investigate the prevalence and outcomes of fungal drug-resistant in COVID-19 patients.

8/22/22

Clinical implications of vascular dysfunction in acute and convalescent COVID-19: a systematic review   

Mavraganis G, Dimopoulou MA, Delialis D, et al. | Eur J Clin Invest

Aim: To synthesize current evidence on the frequency and the prognostic value of vascular dysfunction during acute and post-recovery COVID-19.

8/18/22

New-onset Parkinsonism as a Covid-19 infection sequela: A systematic review and meta-analysis   

Ali SS, Mumtaz A, Qamar MA, et al. | Ann Med Surg

Aim: To highlight Parkinsonism as a post-COVID-19 sequela and helps us understand a possible link between the two.

8/15/22

A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature 

Bryant MC, Spencer LT, Yalcindag A | Pediatr Rheumatol Online J

Aim: To present a case of new-onset AAV following COVID-19 infection in an adolescent patient, and we review the literature of AAV following COVID-19 infection.

8/15/22

Management of Post-Infectious Anosmia and Hyposmia: A Systematic Review   

Nag AK, Saltagi AK, Saltagi MZ, et al. | Ann Otol Rhinol Laryngol

Aim: To establish whether a consensus exists regarding optimal management of olfactory dysfunction and to provide insight into the treatment of anosmia in the current climate of increased prevalence secondary to COVID-19. 

8/9/22

Returning to work and the impact of post COVID-19 condition: A systematic review   

Gualano MR, Rossi MF, Borrelli I, et al. | Work

Aim: To evaluate the impact of lasting COVID-19 symptoms or disability on the working population upon their return to employment.

7/29/22

Systematic Review of COVID-19-Related Physical Activity-Based Rehabilitations: Benefits to Be Confirmed by More Robust Methodological Approaches   

Bailly M, Pélissier L, Coudeyre E, et al. | Int J Environ Res Public Health

Aim: To systematically review the effects of physical activity programs in the recovery of post-COVID-19 patients. 

7/27/22

What might COVID-19 patients experience after recovery? A comprehensive review 

Elhiny R, Al-Jumaili AA, Yawuz MJ | Int J Pharm Pract

Aim: To describe the COVID-19 complications after recovery.

7/15/22

Exercise and long COVID 

 | NSW Health COVID-19 Critical Intelligence Unit

Aim: To review the evidence on the effectiveness of exercise in helping individuals with COVID-19 to recover, and if post-exertional symptom exacerbation is a risk in long COVID.

7/6/22

Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis   

Pinzon RT, Wijaya VO, Jody AA, et al. | J Infect Public Health

Aim: To conduct a systematic review and meta-analysis on the persistent neurological manifestations in COVID-19 survivors.

5/23/22

Pathophysiology and mechanism of long COVID: a comprehensive review 

Castanares-Zapatero D, Chalon P, Kohn L, et al. | Ann Med

Aim: To conduct a comprehensive review to address the putative pathophysiology underlying the persisting symptoms of long COVID.

5/4/22

Breathlessness post COVID-19 

 | NSW Health COVID-19 Critical Intelligence Unit

4/19/22

Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review   

Chen C, Haupert SR, Zimmermann L, et al. | J Infect Dis

Aim: To examine the worldwide prevalence of post COVID-19 condition.

3/31/22

Post COVID-19 Syndrome Clinical Manifestations: A Systematic Review   

Abdel-Gawad M, Zaghloul MS, Abd-Elsalam S, et al. | Antiinflamm Antiallergy Agents Med Chem

Aim: To assess the prevalence of post-COVID-19 manifestations.

2/21/22

ESCMID rapid guidelines for assessment and management of long COVID   

Yelin D, Moschopoulos CD, Margalit I, et al. | Clin Microbiol Infect

Aim: To provide evidence-based recommendations for assessment and management of individuals with persistent symptoms after acute COVID-19 infection, and provide a definition for this entity, termed “long COVID”.

2/14/22

Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review   

Nguyen NN, Hoang VT, Dao TL, et al. | Eur J Clin Microbiol Infect Dis

Aim: To describe the burden of the long-term persistence of clinical symptoms in COVID-19 patients.

1/13/22

Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review   

Macpherson K, Cooper K, Harbour J, et al. | BMJ Open

Aim: To explore the experiences of people living with long COVID and how they perceive the healthcare services available to them.

12/4/21

Care models for long COVID: A rapid systematic review   

Decary S, Dugas M, Stefan T, et al. | SPOR

Aim: To review the evidence on care models for persons living with long COVID.

10/12/21

Long COVID and Post-infective Fatigue Syndrome: A Review 

Sandler CX, Wyller VBB, Moss-Morris R, et al. | Open Forum Infect Dis

Aim: To review the evidence on post-COVID fatigue.

9/30/21

Characterising long COVID: a living systematic review   

Michelen M, Manoharan L, Elkheir N, et al. | BMJ Glob Health

Aim: To regularly synthesise evidence on long COVID characteristics, to help inform clinical management, rehabilitation strategies and interventional studies to improve long-term outcomes.

6/21/21

Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review 

Amdal CD, Pe M, Falk RS, et al. | Qual Life Res

Aim: To identify all relevant health-related quality of life (HRQoL) issues associated with COVID-19.

5/13/21

Frequency, signs and symptoms, and criteria adopted for long COVID: a systematic review   

Martimbianco ALC, Pacheco RL, Bagattini AM, et al. | Int J Clin Pract

Aim: To identify, systematically evaluate and summarise the best available evidence on the frequency of long COVID (post-acute COVID-19 syndrome), its clinical manifestations and the criteria used for diagnosis.

4/26/21

The occurrence of long COVID: a rapid review 

Iwu CJ, Iwu CD, Wiysonge CS | Pan Afr Med J

Aim: To synthesize evidence on the long-term effects of the SARS-CoV-2 infection among survivors.

4/20/21

Assessment of activities of daily living in patients post COVID-19: a systematic review   

Pizarro-Pennarolli C, Sánchez-Rojas C, Torres-Castro R, et al.  | PeerJ

Aim: To understand the impact of COVID-19 on ADL performance of adult patients and to describe the common scales used to assess performance of ADL on patients post-COVID-19.

3/31/21

Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue 

Vollbracht C, Kraft K | Nutrients

Aim: To provide a feasibility analysis of whether the use of intravenous (IV) vitamin C in post-viral fatigue, particularly after COVID-19, should be further investigated.